Presentation of leon-nanodrugs at INV€$TIVAL Showcase
Dr. Michael Mehler, CEO of Leon-nanodrugs presented the company at the Inv€$tival Showcase.
LSX (formerly Biotech and Money) connects corporates to capital, and the Inv€$tival Showcase is our most direct way of showcasing the latest investable private and public life science opportunities to our growing investor network, and that of our partners, Jefferies LLC.
The 4 track Inv€$tival Showcase is designed to highlight the latest innovative companies who are looking to raise capital and their profile amongst investors. It provides an unparalleled opportunity for 1-2-1 investor and B2B meetings in a unique setting, as part of the week of the Jefferies Global Healthcare conference at the The Waldorf Hilton Hotel London
leon-nanodrugs supports Takeda in a feasibility assessment of leon’s proprietary MicroJet Reactor (MJR®) nano-technology
leon-nanodrugs Congratulates its Partner MJR Pharmjet on Receiving Prestigious CPhI Award 2017 for Highly Innovative MicroJet Reactor Technology